World ADC London 2027
World ADC London is Hanson Wade's annual meeting for the antibody drug conjugate field. It runs over four days with a seminar day, two program days and a workshop day.
Monday to Thursday · 4 days
Novotel London West
Hanson Wade
Organizer
Published by the organizer
Every year
How often it's held
Checked October 20, 2026
Reported attendance
700+
ADC industry leaders · year not stated
Reported exhibitors
Not published
About World ADC London 2027
World ADC London is Hanson Wade's annual meeting for the antibody-drug conjugate (ADC) field. The 17th edition runs 8 to 11 March 2027 at the Novotel London West in Hammersmith. It's built for drug developers, clinicians, academics, investors and the CDMOs and service firms that supply them. The organizer bills it at 700+ attendees and 90+ speakers, with five content tracks over four days.
90+
Speakers (2027 target)
43
Speakers named so far for 2027
200+
Companies attending
58%
Director level and above
640
One-on-one meetings scheduled
5
Content tracks
What happens at World ADC London
World ADC London is a four-day scientific conference with an exhibition hall, not a trade fair. The 2027 format opens with a seminar day on Monday 8 March.
That day offers five parallel seminars. They're Introduction to ADCs, Novel Conjugates, Toxicity, ADCs in Combination and Regulatory CMC.
The main program runs Tuesday 9 and Wednesday 10 March. It splits into five tracks covering discovery, preclinical and translational work, clinical lessons, process and analytical development, and manufacturing and supply chain.
Day One opens with a CEO and pharma leaders think tank and ends with a poster session and drinks reception. Thursday 11 March is a workshop day on topics such as payload chemistry, AI models, ADC patents and CDMO selection.
A licensing, partnering and investment session brings business development leads, biotechs and investors together on ADC dealmaking. Researchers can also submit a poster abstract by 15 February 2027.
What's new for World ADC London 2027
The headline change is the venue move to the Novotel London West. The organizer says the new venue and layout are designed to increase networking and booth footfall.
It's also adding a Grip-powered partnering platform, networking sessions grouped by ADC specialism and private meeting spaces. The 2027 program focuses on resistance, dual-payload ADCs and earlier lines of treatment.
Readers following European life science events may also look at BIO-Europe Spring 2027, Swiss Biotech Day 2027 and BioProcess International Europe 2027.
Who attends World ADC London
The audience is senior scientists and decision-makers working on ADCs. The organizer cites 700+ attendees, 200+ companies and 58% at director level or above, without saying which edition those figures count.
Its event overview describes attendees from pharma, biotech and the clinic alongside technology and solution providers. The same page says they come from Europe, the United States, Asia and beyond.
Large drug makers appear among the named attendees. The organizer lists Pfizer, Roche, AbbVie, Daiichi Sankyo, Merck, AstraZeneca and Amgen among attending companies, with logos tagged to the 2026 edition.
Before the 2026 meeting, the organizer's site promised 240+ companies in the room and 110+ speakers. It also reported 640 one-on-one meetings scheduled at the 2025 edition.
Detailed breakdowns by job title, seniority and company type sit in the partnership prospectus, which the organizer gives out through a download form.
Attendance and exhibitors by year
As the organizer reports them. What's counted varies between events, so compare with care.
| Edition | Attendance |
|---|---|
| Not stated | 700+ADC industry leadersHeadline figure on the organizer's 2027 page. It doesn't say which edition it counts.worldadc-europe.com ↗ |
Companies at World ADC London 2027
Most named companies at the 2027 edition so far are CDMOs, CROs and tool suppliers. They're listed on the official partner page, and drug developers appear on the speaker list.
Sponsors (26)WuXi XDC, BSP Pharmaceuticals, Lonza and 23 more
- WuXi XDC · 2027Lead partner
- BSP Pharmaceuticals · 2027Senior partner
- Lonza · 2027Senior partner
- Piramal Pharma Solutions · 2027Senior partner
- SK pharmteco · 2027Senior partner
- Abzena · 2027Program partner
- Ajinomoto · 2027Program partner
- AsymBio · 2027Program partner
- Axplora · 2027Program partner
- Beacon by Hanson Wade · 2027Program partner, the organizer's own database product
- Cytiva · 2027Program partner
- Genovis · 2027Program partner
- HUB Organoids · 2027Program partner
- Intertek · 2027Program partner
- Lide Biotech · 2027Program partner
- MabPlex · 2027Program partner
- Merck KGaA · 2027Program partner, listed as Merck kga
- Nona Biosciences · 2027Program partner
- Olon · 2027Program partner
- Pharmaron · 2027Program partner
- Shilpa Pharma · 2027Program partner
- Simtra BioPharma Solutions · 2027Program partner
- Sterling Pharma Solutions · 2027Program partner
- Veranova · 2027Program partner
- Proveo · 2027Hosting partner
- Certara · 2026Program partner, panel on model-informed drug development
Exhibitors (20)Biocytogen, BioPharmaSpec, Cohance and 17 more
- Biocytogen · 2027Exhibition partner
- BioPharmaSpec · 2027Exhibition partner
- Cohance · 2027Exhibition partner
- Fyoni Bio · 2027Exhibition partner
- Glycogene · 2027Exhibition partner
- Huida Biotech · 2027Exhibition partner
- ILC Dover · 2027Exhibition partner
- Indena · 2027Exhibition partner
- LeanBio · 2027Exhibition partner
- Procos · 2027Exhibition partner
- ProJect Pharmaceutics · 2027Exhibition partner
- Quality Assistance · 2027Exhibition partner
- Savillex · 2027Exhibition partner, with ONFAB
- ChemExpress · 2027Exhibition partner, listed as Shanghai Haoyuan Chemexpress
- TAPI · 2027Exhibition partner
- ChemPartner · 2026Booth 35 at ExCeL London, ADC poster
- Ardena · 2026Booth 33
- Abzena · 2026Booth 59
- Apeloa · 2026CDMO, on site to discuss payload and conjugation work
- TAPI · 2026Showcased ADC CDMO services
Speakers' companies (1)Sutro Biopharma
Attending (10)Evotec, Pfizer, Roche and 7 more
- Evotec · 2026Invited meetings at the 2026 edition
- Pfizer · 2026Under 'Attending Companies Include', logo tagged 16th World ADC London
- Roche · 2026Under 'Attending Companies Include', logo tagged 16th World ADC London
- AbbVie · 2026Under 'Attending Companies Include', logo tagged 16th World ADC London
- Daiichi Sankyo · 2026Under 'Attending Companies Include', logo tagged 16th World ADC London
- Merck · 2026Under 'Attending Companies Include', logo tagged 16th World ADC London
- AstraZeneca · 2026Under 'Attending Companies Include', logo tagged 16th World ADC London
- Amgen · 2026Under 'Attending Companies Include', logo tagged 16th World ADC London
- Salubris Bio · 2026Under 'Attending Companies Include', logo tagged 16th World ADC London
- Iksuda Therapeutics · 2026Under 'Attending Companies Include', logo tagged 16th World ADC London
The list below shows confirmed 2027 partners first, then companies that announced their own participation at the 2026 edition.
Exhibitors at World ADC London
Exhibitors at World ADC London are service and technology providers that book booths through a partnership package. The 2027 partner page lists 15 exhibition partners so far, including Biocytogen, BioPharmaSpec, ILC Dover, Indena and TAPI.
Most are CDMOs, CROs, payload and linker suppliers and analytical labs. The 2026 edition listed more than 30 exhibition partners, among them Curia, Promega, PPD and Unchained Labs.
The exhibition hall hosts the poster area, coffee breaks and the meeting zone on both main days. The organizer calls the 2027 layout new and designed to raise booth footfall.
There's no public booth price list. The organizer asks companies to contact its partnerships team for a tailored package covering booths, speaking slots and branding.
Exhibitors who want to qualify booth visitors can compare lead retrieval apps before the show.
Sponsors and partners at World ADC London 2027
World ADC London sells sponsorship in tiers. The 2027 partner page names a lead partner, four senior partners, 19 program partners, a hosting partner and 15 exhibition partners.
WuXi XDC is lead partner. BSP Pharmaceuticals, Lonza, Piramal Pharma Solutions and SK pharmteco are senior partners.
Program partners include Abzena, Ajinomoto, Axplora, Cytiva, Genovis, Intertek, Merck KGaA, Olon, Pharmaron, Sterling Pharma Solutions and Veranova. Proveo is hosting partner.
The why partner page says packages can include speaking slots, exhibition booths, networking sponsorships and branding. Service providers pay a higher delegate rate, and the registration page points them to sponsorship instead.
Media partners for 2027 include Contract Pharma, ADC Review, BioPharma Asia and Pharma Focus Europe. Teams weighing these packages can compare event sponsorship software.
The event's tech
We couldn't identify a third-party registration platform on the event's website.
World ADC London attendee list, exhibitor list and sponsor list
Exhibitor list
Published
Sponsor list
Published
Attendee list
Not published or sold
World ADC London doesn't publish an attendee list. The partner page serves as the official sponsor and exhibitor list, grouped by tier.
Instead of a list, delegates use the event app to book meetings. For 2027 the organizer is launching a new partnering platform powered by Grip, the Grip matchmaking platform.
That kind of event matchmaking runs on both main days, with private meeting spaces. Attendee breakdowns appear only in the gated prospectus.
The organizer warns about fraudulent hotel booking schemes from third parties claiming to represent Hanson Wade. It says accommodation details only come from your event manager.
Treat offers to sell a World ADC London attendee list with the same caution. Our guide on how to find who's attending an event explains what's legitimately available, and we compare event intelligence platforms.
See who's attending World ADC London
Organizers don't publish attendee lists. These event intelligence platforms show which companies and roles are likely to attend and help you book meetings. How to find who's attending
Speakers at World ADC London 2027
Hanson Wade has named 43 speakers for the 2027 edition so far, against a target of 90+. The lineup mixes large pharma, biotech founders, clinicians and academics.
- Robert LutzChief Scientific Officer, Iksuda TherapeuticsPanelist · Panel discussion on next-generation ADCs, XDCs and dual-payload innovation (Day One) · 2027
- Dragan GrabulovskiChief Executive Officer, Araris BiotechCEO and ADC Pharma Leaders Think Tank (Day One) · 2027
- Christian RohlffChief Executive Officer, Oxford BiotherapeuticsCEO and ADC Pharma Leaders Think Tank (Day One) · 2027
- Evelyn FahrenkrugGlobal Commercial Head Oncology Pipeline, Boehringer IngelheimCEO and ADC Pharma Leaders Think Tank (Day One) · 2027
- Dave SimpsonChief Executive Officer, Iksuda TherapeuticsCEO and ADC Pharma Leaders Think Tank (Day One) · 2027
- John LambertConsultant and Honorary Professor, Queen's University BelfastPanelist · Panel discussion on next-generation ADCs (Day One) and Introduction to ADCs Day · 2027
- Greg ThurberProfessor, Chemical and Biomedical Engineering, University of MichiganPanelist · Panel discussion on next-generation ADCs (Day One) · 2027
- Jeremy SauerVice President, Strategy, Callio TherapeuticsPanelist · Panel discussion on next-generation ADCs (Day One) · 2027
All speakers (35)Min Hu, Scott Lesley, Matthew Sender and 32 more
- Min HuSenior Vice President, Oncology Discovery, Innovent BiologicsOver the Horizon, the Dual Payload Innovation (Day One) · 2027
- Scott LesleyPresident and Chief Scientific Officer, InduProTAPAs, a new class of ADC targets (Day One) · 2027
- Matthew SenderDirector and ADC Project Lead, LigaChem BiosciencesLCB43, a next-generation BCMA ADC (Day One) · 2027
- Samuel MurphyChief Executive Officer, Salubris BiotherapeuticsJK06 biparatopic 5T4-targeted ADC (Day One) · 2027
- Osama ChahrourPrincipal Scientist, New Modalities, AstraZenecaImpurity thresholds in drug-linker intermediates (Day One) · 2027
- Tobias GustavsonSenior Director, Bioconjugation and CMC, VAR2 PharmaceuticalsDevelopment and manufacturing of the VARTUMAB ADC (Day One) · 2027
- Marc RobillardCo-Founder and Chief Scientific Officer, Tagworks PharmaceuticalsClick-to-Release ADCs (Day Two) · 2027
- Kevin HamblettSenior Director, ADC Pharmacology, PfizerPF-08052667 for non-muscle invasive bladder cancer (Day Two) · 2027
- Tingting CuiAssociate Director, AstraZenecaA scalable lysine bioconjugation platform (Day Two) · 2027
- Rakesh DixitPresident and Chief Executive Officer, Bionavigen OncologyToxicity Day preview session · 2027
- David IllescasClinical Investigator, Arrixaca University HospitalADCs in Combination Day preview session · 2027
- Eugenio Cardenal VigilAssociate Director, Regulatory Affairs CMC, Johnson & JohnsonRegulatory CMC Day preview session · 2027
- Robert AndrewsADC and Conjugate Patent Strategy (European Patent Attorney), Mewburn Ellis LLPWorkshop C on the ADC IP landscape · 2027
- Nicola BeltraminelliADC Bioprocess Expert, Pierre FabreWorkshop F on process development for complex ADCs · 2027
- Alireza TafazzolSenior Scientist, AbbVie2027
- Alan RussellVice President, Research and Head, R&D Technology and Innovation, Amgen2027
- Elena de OrbeAssociate Principal, Computational Chemist, AstraZeneca2027
- Yu-Shin HsuSenior Research Analyst, Beacon Intelligence2027
- Javad ShahidiSenior Vice President, Head of Biotech Unit and Development Innovation, BeOne Medicines2027
- Yuan-An (Angus) LiuDirector Protein and ADC Drug Product, BioNTech2027
- Wim DokterChief Scientific Officer, Byondis2027
- Charles DumontetDeputy Director and Investigator, Cancer Research Centre of Lyon2027
- Giorgio MassiminiChief Medical Officer, CanWell Pharma2027
- Hong Zebger-GongSenior Medical Director, Global Oncology Clinical Development, Daiichi Sankyo2027
- Leo MarxHead of ADC Research and Technologies, Debiopharm2027
- Jesús Fuentes AntrásMedical Oncologist and Clinical Investigator, Hospital Universitario Quirónsalud Madrid2027
- Jerome Boyd-KirkupChief Scientific Officer and Co-Founder, Hummingbird Bioscience2027
- Kurt PikeSenior Director, Discovery Product Development and Supply External Innovation, Johnson & Johnson2027
- Mike SeganishDistinguished Scientist and Executive Director, Scientific Discovery, Merck & Co2027
- Valerie VanhoorenChief Executive Officer, Ona Therapeutics2027
- Alain BeckSenior Director, Biologics CMC Developability, Pierre Fabre2027
- Floriana CremascoSenior Scientist, Roche2027
- Ines Grazina de MatosPrincipal Scientist, Roche2027
- Harold KeerChief Medical Officer, Taiho Oncology2027
- Ali SalantiCo-Founder and Chief Executive Officer, VAR2 Pharmaceuticals2027
The Day One CEO and ADC Pharma Leaders Think Tank features Robert Lutz and Dave Simpson of Iksuda Therapeutics. Dragan Grabulovski of Araris Biotech, Christian Rohlff of Oxford Biotherapeutics and Evelyn Fahrenkrug of Boehringer Ingelheim join them.
A panel on dual-payload ADCs and XDCs includes John Lambert of Queen's University Belfast and Greg Thurber of the University of Michigan. Jeremy Sauer of Callio Therapeutics and Robert Lutz also sit on it.
Track talks include Kevin Hamblett of Pfizer on a bladder cancer ADC and Min Hu of Innovent Biologics on dual-payload design. Other named speakers come from AstraZeneca, Roche, Daiichi Sankyo, Johnson & Johnson, BioNTech and Amgen.
At the 2026 edition, the organizer listed more than 110 speakers. They included Hans-Peter Gerber of Sutro Biopharma, who presented on dual-payload ADCs, and Paolo Tarantino of Dana-Farber Cancer Institute.
Solution providers can secure speaking opportunities as part of a partnership package. Drug developers who want to share data can also submit a poster abstract.
Who spoke at World ADC London 2026 (16)
- Shilpen Patel, Global Development Leader, AbbVie
- Elaine Hurt, Executive Director, AstraZeneca
- Guillaume Bergthold, Executive Director, Clinical Development, Daiichi Sankyo
- Luisa Freitas dos Santos, Vice President, Global Clinical Supply Chain, GSK
- Natalie Grinshtein, Director ADC Discovery, Pfizer Oncology, Pfizer
- Hans-Peter Gerber, Chief Scientific Officer, Sutro Biopharma
- Jimmy Li, Chief Executive Officer, WuXi XDC
- Sean McCarthy, Chief Executive Officer, CytomX Therapeutics
- Ya-Chi Chen, Chief Scientific Officer, OBI Pharma
- Zhenwei Miao, Founder and Chairman, Adcoris Biopharma
- Tim Mollner, Senior Expert, Novartis
- Stuart Barnscher, Senior Director, Preclinical Programs, ADC Therapeutic Development, Zymeworks
- Saskia Schmitt, Director, Biology, Tubulis
- Paolo Tarantino, Clinical Research Fellow, Dana-Farber Cancer Institute
- Christian Merz, Assessor, Non-Clinical and Quality, Antibody Therapeutics, Paul-Ehrlich-Institut
- Shyam Masrani, Partner, Medicxi
Dates, venue and getting there
The 17th World ADC London runs 8 to 11 March 2027. The seminar day is Monday 8 March, the main program is Tuesday and Wednesday, and workshops close the week on Thursday.
The venue is the Novotel London West at 1 Shortlands in Hammersmith, west London. The organizer's venue page links to it and gives the W6 8DR postcode.
The 2026 edition ran at ExCeL London in the Royal Docks, so 2027 moves the meeting to a hotel venue in west London.
Many visitors to the UK now need an Electronic Travel Authorisation from the UK government. The organizer's registration page reminds delegates to check this before travel.
Tickets and registration
World ADC London is a paid conference with separate rates for drug developers, academics and service providers. All prices are in British pounds and exclude VAT, and bookings are subject to approval.
Checked in October 2026, a drug developer conference-only pass cost £2,210 for bookings by Friday 23 October. The on-the-door price is £2,860.
The full drug developer package with seminar and workshop days cost £4,070. Academics paid from £1,650 for the conference only.
Service providers paid from £3,090 for the conference only and £6,030 for the full package. Drug developer rates apply only to companies with a public pipeline that don't sell services.
Group discounts run from 10% for three delegates to 20% for seven or more from one company, booked and paid together.
History of World ADC London
World ADC London reaches its 17th edition in 2027. The organizer says it has been the field's forum for 17 years.
The 16th edition ran 23 to 26 February 2026 at ExCeL London. Its organizer site billed 700+ attendees and more than 110 speakers.
It's part of Hanson Wade's World ADC series, which also runs ADC San Diego in October and ADC Korea in June.
Resources for exhibitors, sponsors and attendees
These official World ADC London pages cover registration, the program and partnering.
- Pricing and registrationFor drug developer, academic and service provider passes.
- Speaker facultyFor the 17th edition.
- Day One programAnd Day Two program with track sessions.
- Seminar dayAnd workshop day agendas.
- 2027 partnersBy tier, the official sponsor and exhibitor list.
- Why partnerWith sponsorship options and partnership contacts.
- Partnership prospectus requestWith audience statistics, behind a download form.
- Poster session rulesAnd the abstract deadline.
- Networking calendarWith the partnering platform and exhibition hall times.
- Venue and accommodationWith the hotel booking scam warning.